OSRH (OSR Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

OSRH (OSR Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena

OSRHOSR Holdings, Inc.

Mkt Cap$13M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$3M

Net Income (TTM)-$21M

EPS (TTM)-$4.87

Free Cash Flow (TTM)-$4M

Gross Margin18.3%

Op. Margin-558.3%

Net Margin-822.6%

FCF Margin-149.0%

P/S Ratio (TTM)5.0x

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$14K
Q1 23	$0	$0	-$278K
Q2 23	$0	$0	-$280K
Q3 23	$0	$0	-$410K
Q4 23	$0	$0	-$862K
Q1 24	$0	$0	-$451K
Q2 24	$0	$0	-$476K
Q3 24	$0	$0	-$454K
Q4 24	$0	$0	-$2M
Q1 25	$761K	$169K	-$3M
Q2 25	$1M	$33K	-$5M
Q3 25	$628K	$262K	-$4M

Valuation

Quarter	P/S	P/E
Q4 22	—	—
Q1 23	—	167.7x
Q2 23	—	33.3x
Q3 23	—	26.5x
Q4 23	—	31.2x
Q1 24	—	54.0x
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	16.5x	—
Q2 25	6.6x	—
Q3 25	5.0x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$952	-$952
Q1 23	-$48K	-$48K
Q2 23	-$348K	-$348K
Q3 23	-$143K	-$143K
Q4 23	-$279K	-$279K
Q1 24	-$42K	-$42K
Q2 24	-$1M	-$1M
Q3 24	-$227K	-$227K
Q4 24	-$503K	-$503K
Q1 25	-$64K	-$64K
Q2 25	-$44K	-$44K
Q3 25	-$3M	-$3M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$0
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$0
Q2 24	$2
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$4
Q3 25	$4

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	—	+4326.1%
Q1 23	—	+220534.9%
Q2 23	—	+28240.1%
Q3 23	—	+1947.7%
Q4 23	—	+5948.3%
Q1 24	—	+62.2%
Q2 24	—	+70.0%
Q3 24	—	+10.7%
Q4 24	—	+148.7%
Q1 25	—	+715.8%
Q2 25	—	+1237.1%
Q3 25	—	+876.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	—
Q1 23	$0	—
Q2 23	$0	—
Q3 23	$0	—
Q4 23	$0	—
Q1 24	$0	—
Q2 24	$0	—
Q3 24	$0	—
Q4 24	$0	—
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	G&A	SG&A
Q4 22	$14K	—
Q1 23	$278K	—
Q2 23	$280K	—
Q3 23	$410K	—
Q4 23	$862K	—
Q1 24	$451K	—
Q2 24	$476K	—
Q3 24	$454K	—
Q4 24	$2M	—
Q1 25	—	$3M
Q2 25	—	$5M
Q3 25	$4M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$125K	$0	$125K
Q1 23	$349K	$0	$349K
Q2 23	$1K	$0	$1K
Q3 23	$58K	$0	$58K
Q4 23	$15K	$0	$15K
Q1 24	$4K	$0	$4K
Q2 24	$119K	$0	$119K
Q3 24	$12K	$0	$12K
Q4 24	$66K	$0	$66K
Q1 25	$2M	$0	$2M
Q2 25	$2M	$0	$2M
Q3 25	$2M	$0	$2M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	9M	+14.2%
Q1 23	9M	+0.0%
Q2 23	9M	+0.0%
Q3 23	9M	+0.0%
Q4 23	7M	-18.2%
Q1 24	6M	-24.1%
Q2 24	4M	-28.1%
Q3 24	4M	+0.0%
Q4 24	4M	+10.9%
Q1 25	4M	+0.0%
Q2 25	4M	+0.0%
Q3 25	4M	+0.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 20	—	—
FY 21	—	—
FY 22	$0	2
FY 23	$0	2
FY 24	$0	5